Cargando…
Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells
AIM: The aim of the study was to investigate whether miR-126, a regulator of MAPK signaling via targeting sprouty-related EVH1 domain-containing protein 1 (SPRED1) mRNA, is involved in the process by which icariside II (ICA II) ameliorates endothelial dysfunction in human cavernous endothelial cells...
Autores principales: | Lei, Hongen, Li, Huixi, Tian, Long, Li, Meng, Xin, Zhongcheng, Zhang, Xiaodong, Guan, Ruili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005314/ https://www.ncbi.nlm.nih.gov/pubmed/29942117 http://dx.doi.org/10.2147/DDDT.S166734 |
Ejemplares similares
-
AB238. Effect of Icariside II on miR-126 pathway on human cavernous endothelial cells exposed to a diabetic-like environment
por: Lei, Hongen, et al.
Publicado: (2016) -
AB239. Icariside II enhances endothelial nitric oxide synthase expression by suppressing miR-155 in diabetic-like human cavernous endothelial cells
por: Guan, Ruili, et al.
Publicado: (2016) -
AB037. Icariside II improves human cavernous endothelial cells function by regulating miR-155/eNOS signal pathway
por: Guan, Ruili, et al.
Publicado: (2016) -
AB178. Molecular biology for genitourinary system diseases and sexual dysfunction icariside II prevents high-glucose-induced injury on human cavernous endothelial cells through Akt-eNOS signaling pathway
por: Li, Huixi, et al.
Publicado: (2015) -
AB184. Icariside II induces NO production in human cavernous endothelial cells via the activation of eNOS by miR-155
por: Lei, Hongen, et al.
Publicado: (2015)